Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
2.670
+0.070 (2.69%)
At close: Apr 2, 2025, 4:00 PM
2.510
-0.160 (-5.99%)
After-hours: Apr 2, 2025, 7:12 PM EDT

Revelation Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-15.04-0.12-10.83-11.99-3.8
Depreciation & Amortization
0.030.030.030.02-
Stock-Based Compensation
0.190.160.30.470.04
Other Operating Activities
-0.08-8.330.010.05-
Change in Accounts Payable
-0.580.75-0.67-0.271.3
Change in Other Net Operating Assets
-2.850.23-0.060.630.32
Operating Cash Flow
-18.32-7.29-11.22-11.09-2.13
Capital Expenditures
-0.02---0.13-
Investing Cash Flow
-0.02---0.13-
Short-Term Debt Issued
--2.5--
Total Debt Issued
--2.5--
Short-Term Debt Repaid
---2.5--
Long-Term Debt Repaid
---0.8--
Total Debt Repaid
---3.3--
Net Debt Issued (Repaid)
---0.8--
Issuance of Common Stock
12.8514.0311.720.68.26
Repurchase of Common Stock
---7.65--
Other Financing Activities
--11.92--
Financing Cash Flow
12.8514.0315.288.87
Net Cash Flow
-5.496.743.98-3.226.74
Free Cash Flow
-18.34-7.29-11.22-11.22-2.13
Free Cash Flow Per Share
-106.94-511.46---
Levered Free Cash Flow
-8.34-4.11-3.66-6.71-
Unlevered Free Cash Flow
-8.34-4.11-3.66-6.71-
Change in Net Working Capital
3.56-1.12-2.8-0.41-
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q